Clario's arrhythmia analysis solutions provide reliable continuous ECG data collection for clinical trials, offering flexible options for both in-clinic and at-home monitoring. With over 40 years of experience in Holter arrhythmia analysis, Clario delivers consistent and high-quality cardiac safety data to help address one of the leading reasons promising drugs are delayed or abandoned. The company offers two main product options: Patch Arrhythmia, which utilizes patient-friendly devices for up to 14 days of wire-free recording, and Holter Arrhythmia, which provides detailed 24-48 hour cont...
Vendor
Clario
Company Website
Clario's arrhythmia analysis solutions enable sponsors to collect reliable continuous ECG data for clinical trials, either in-clinic or at home, using flexible technology and patient-friendly devices. With over 40 years of experience in Holter arrhythmia analysis, Clario provides consistent and high-quality cardiac safety data, addressing one of the primary reasons promising drugs face delays or abandonment. The company offers two main product options: Patch Arrhythmia and Holter Arrhythmia, both designed to meet specific compound requirements, site locations, and evolving regulatory needs
Key Features
Patch Arrhythmia Leverages deep Holter arrhythmia knowledge with patient-friendly devices
- Flexible recording options for up to 14 days
- Wire-free single and dual-channel recording options
Holter Arrhythmia Provides detailed continuous ECG data for comprehensive analysis
- Continuous 12-lead ECG Holter solution for 24-48 hour increments
- Over 40 years of experience ensuring consistent, reliable arrhythmia data
Benefits
Enhanced Data Quality Ensures high-quality, consistent ECG data collection
- Global logistics support for clinical trial quality data
- Tailored solutions to meet specific study requirement
Improved Patient Experience Offers more comfortable and convenient monitoring options
- Patient-friendly devices for increased compliance
- Flexible at-home and in-clinic monitoring options